CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin

Molecular Metabolism

Volumn 3, Issue 7, 2014, Pages 705-716

  Cardinal, Pierre ^a,b   André, Caroline ^a,b   Quarta, Carmelo ^c   Bellocchio, Luigi ^a,b,d   Clark, Samantha ^a,b   Elie, Melissa ^a,b   Leste Lasserre, Thierry ^a,b   Maitre, Marlene ^a,b   Gonzales, Delphine ^a,b   Cannich, Astrid ^a,b   Pagotto, Uberto ^c   Marsicano, Giovanni ^a,b   Cota, Daniela ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

CB1 receptor; Endocannabinoid; Hypothalamus; Leptin; Obesity; Ventromedial nucleus

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; STAT3 PROTEIN; STEROIDOGENIC FACTOR 1; TRIACYLGLYCEROL LIPASE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIMETRY; CONTROLLED STUDY; DIET; ENERGY BALANCE; FAT MASS; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD COMPOSITION; FOOD INTAKE; GENE DELETION; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GONAD; HYPERPHAGIA; IMMUNOHISTOCHEMISTRY; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LIPID OXIDATION; LIPOLYSIS; LOCOMOTION; MALE; METABOLIC ACTIVATION; METABOLISM; MOUSE; NERVE CELL; NONHUMAN; OBESITY; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY QUOTIENT; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; WEIGHT GAIN; WESTERN BLOTTING; WHITE ADIPOSE TISSUE; ZONA INCERTA;

EID: 84908208686     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.07.004     Document Type: Article

References (52)

1. Popkin B.M. Understanding global nutrition dynamics as a step towards controlling cancer incidence. Nature Reviews Cancer 2007, 7(1):61-67.
2. Ryan K.K., Woods S.C., Seeley R.J. Central nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposity. Cell Metabolism 2012, 15(2):137-149.
3. Cota D., Proulx K., Seeley R.J. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 2007, 132(6):2158-2168.
4. Ryan K.K., Seeley R.J. Physiology. Food as a hormone. Science 2013, 339(6122):918-919.
5. Bermudez-Silva F.J., Cardinal P., Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of Psychopharmacology 2012, 26(1):114-124.
6. Quarta C., Mazza R., Obici S., Pasquali R., Pagotto U. Energy balance regulation by endocannabinoids at central and peripheral levels. Trends in Molecular Medicine 2011, 17(9):518-526.
7. DiPatrizio N.V., Astarita G., Schwartz G., Li X., Piomelli D. Endocannabinoid signal in the gut controls dietary fat intake. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(31):12904-12908.
8. Lafourcade M., Larrieu T., Mato S., Duffaud A., Sepers M., Matias I., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nature Neuroscience 2011, 14(3):345-350.
9. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience 1991, 11(2):563-583.
10. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience 1999, 11(12):4213-4225.
11. King B.M. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiology & Behavior 2006, 87(2):221-244.
12. Ikeda Y., Shen W.H., Ingraham H.A., Parker K.L. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Molecular Endocrinology 1994, 8(5):654-662.
13. Ikeda Y., Luo X., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Molecular Endocrinology 1995, 9(4):478-486.
14. Majdic G., Young M., Gomez-Sanchez E., Anderson P., Szczepaniak L.S., Dobbins R.L., et al. Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 2002, 143(2):607-614.
15. Lindberg D., Chen P., Li C. Conditional viral tracing reveals that steroidogenic factor 1-positive neurons of the dorsomedial subdivision of the ventromedial hypothalamus project to autonomic centers of the hypothalamus and hindbrain. Journal of Comparative Neurology 2013, 521(14):3167-3190.
16. Dhillon H., Zigman J.M., Ye C., Lee C.E., McGovern R.A., Tang V., et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 2006, 49(2):191-203.
17. Xu Y., Hill J.W., Fukuda M., Gautron L., Sohn J.W., Kim K.W., et al. PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis. Cell Metabolism 2010, 12(1):88-95.
18. Zhang R., Dhillon H., Yin H., Yoshimura A., Lowell B.B., Maratos-Flier E., et al. Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology 2008, 149(11):5654-5661.
19. Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. British Journal of Pharmacology 2001, 134(6):1151-1154.
20. Kim K.W., Jo Y.H., Zhao L., Stallings N.R., Chua S.C., Parker K.L. Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleus. Molecular Endocrinology 2008, 22(8):1950-1961.
21. Bellocchio L., Soria-Gómez E., Quarta C., Metna-Laurent M., Cardinal P., Binder E., et al. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB(1) receptor blockade. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(12):4786-4791.
22. Cardinal P., Bellocchio L., Clark S., Cannich A., Klugmann M., Lutz B., et al. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology 2012, 153(9):4136-4143.
23. Cota D., Matter E.K., Woods S.C., Seeley R.J. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. Journal of Neuroscience 2008, 28(28):7202-7208.
24. Galie M., Farace P., Nanni C., Spinelli A., Nicolato E., Boschi F., et al. Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism. Neoplasia 2007, 9(11):900-908.
25. Binder E., Bermúdez-Silva F.J., Elie M., Leste-Lasserre T., Belluomo I., Clark S., et al. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice. Obesity (Silver Spring) 2013, 22(3):713-720.
26. Proulx K., Cota D., Woods S.C., Seeley R.J. Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system. Diabetes 2008, 57(12):3231-3238.
27. Scott M.M., Lachey J.L., Sternson S.M., Lee C.E., Elias C.F., Friedman J.M., et al. Leptin targets in the mouse brain. Journal of Comparative Neurology 2009, 514(5):518-532.
28. Kahn S.E., Prigeon R.L., Schwartz R.S., Fujimoto W.Y., Knopp R.H., Brunzell J.D., et al. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. Journal of Nutrition 2001, 131(2):354S-360S.
29. Bartness T.J., Shrestha Y.B., Vaughan C.H., Schwartz G.J., Song C.K. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Molecular and Cellular Endocrinology 2010, 318(1-2):34-43.
30. Nogueiras R., Lopez M., Dieguez C. Regulation of lipid metabolism by energy availability: a role for the central nervous system. Obesity Reviews 2010, 11(3):185-201.
31. Quarta C., Bellocchio L., Mancini G., Mazza R., Cervino C., Braulke L.J., et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism 2010, 11(4):273-285.
32. Ruffin M., Nicolaidis S. Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior. Brain Research 1999, 846(1):23-29.
33. Anthonsen M.W., Rönnstrand L., Wernstedt C., Degerman E., Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. The Journal of Biological Chemistry 1998, 273(1):215-221.
34. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306(5700):1383-1386.
35. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annual Review of Physiology 2008, 70:537-556.
36. Buettner C., Muse E.D., Cheng A., Chen L., Scherer T., Pocai A., et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nature Medicine 2008, 14(6):667-675.
37. Scherer T., Buettner C. Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism. Reviews in Endocrine and Metabolic Disorders 2011, 12(3):235-243.
38. Holm C., Osterlund T., Laurell H., Contreras J.A. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annual Review of Nutrition 2000, 20:365-393.
39. Ravinet Trillou C., Delgorge C., Menet C., Arnone M., Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. International Journal of Obesity and Related Metabolic Disorders 2004, 28(4):640-648.
40. Kim K.W., Zhao L., Donato J., Kohno D., Xu Y., Elias C.F., et al. Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(26):10673-10678.
41. Myers M.G., Leibel R.L., Seeley R.J., Schwartz M.W. Obesity and leptin resistance: distinguishing cause from effect. Trends in Endocrinology & Metabolism 2010, 21(11):643-651.
42. Sakaguchi T., Bray G.A., Eddlestone G. Sympathetic activity following paraventricular or ventromedial hypothalamic lesions in rats. Brain Research Bulletin 1988, 20(4):461-465.
43. Vander Tuig J.G., Knehans A.W., Romsos D.R. Reduced sympathetic nervous system activity in rats with ventromedial hypothalamic lesions. Life Sciences 1982, 30(11):913-920.
44. Satoh N., Ogawa Y., Katsuura G., Numata Y., Tsuji T., Hayase M., et al. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 1999, 48(9):1787-1793.
45. Di Marzo V., Goparaju S.K., Wang L., Liu J., Bátkai S., Járai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410(6830):822-825.
46. Jo Y.H., Chen Y.J., Chua S.C., Talmage D.A., Role L.W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 2005, 48(6):1055-1066.
47. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., et al. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. Journal of Neuroscience 2006, 26(24):6643-6650.
48. Sternson S.M., Shepherd G.M., Friedman J.M. Topographic mapping of VMH→ arcuate nucleus microcircuits and their reorganization by fasting. Nature Neuroscience 2005, 8(10):1356-1363.
49. Andersson D., Wahrenberg H., Lofgren P. Beta3-adrenoceptor function and long-term changes in body weight. International Journal of Obesity (London) 2009, 33(6):662-668.
50. Le Foll C., Irani B.G., Magnan C., Dunn-Meynell A.A., Levin B.E. Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. The American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2009, 297(3):R655-R664.
51. López M., Varela L., Vázquez M.J., Rodríguez-Cuenca S., González C.R., Velagapudi V.R., et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine 2010, 16(9):1001-1008.
52. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. The Journal of Biological Chemistry 2005, 280(26):25196-25201.